Type of Cancer
There are many types of cancer treatment. The types of treatment that you receive will depend on the type of cancer you have and how advanced it is.
Some people with cancer will have only one treatment. But most people have a combination of treatments, such as surgery with chemotherapy and radiation therapy.
When you need treatment for cancer, you have a lot to learn and think about. It is normal to feel overwhelmed and confused.
But, talking with your doctor and learning about the types of treatment you may have can help you feel more in control.
Cancer is a complex disease with many types and stages, each requiring a unique approach to treatment. The type and stage of cancer significantly influence the treatment options available. Additionally, factors such as Nagalase levels, age, general bloodwork, tomography, medical history, drugs taken, liver and kidney function, diet, lifestyle, exposure to fungi and heavy metals, dental issues, exposure to some chemicals including PAH’S and weedkillers, hormone imbalances, nutrient deficiencies, toxin overload, asbestos exposure and gut flora and other precursors to Cancer, must be considered when developing a treatment plan for cancer patients. Finding a cause is important as is the physiological side to cancer which effects more than the patient.
Personalized Cancer Therapies
To achieve the best outcomes, cancer therapies should be tailored to the individual. This personalized approach ensures that all relevant factors are taken into account, providing a comprehensive treatment strategy.
Navigating Cancer Treatment
When faced with a cancer diagnosis, there is a lot to learn and consider. It is normal to feel overwhelmed and confused. However, consulting with healthcare professionals and educating yourself about the available treatment options can help you feel more in control and better prepared to make informed decisions about your care.
How GcMAF works
How GcMaf immunotherapy works
Doctor’s Guidance on GcMAF Dosage for Serious Health Conditions
Insights from Over 7 Years of Clinical Experience
As a physician who has worked extensively within a team specializing in GcMAF therapy for over seven years. I’m pleased to share detailed guidance on the GcMAF dosing protocols we’ve employed with patients facing various forms of cancer and other serious illnesses. This information is based on real-world clinical experience and aims to provide clarity for those seeking immune-modulating support through GcMAF.
Our medical group maintains a focused approach, GcMaF is the central therapeutic agent used in our protocols.
Initial Testing & Monitoring
Before initiating GcMAF therapy, we recommend the following diagnostic steps:
Nagalase Testing: A rapid Nagalase kit is used to assess baseline enzyme levels. Nagalase is re-tested after 3 months to monitor response.
Vitamin D3 Assessment: A 25-hydroxy blood test determines D3 levels, as adequate vitamin D3 is essential for GcMAF efficacy.
Administration Method
GcMAF is typically administered via subcutaneous (SC) or intramuscular (IM) injection. In our hospital, subcutaneous injections into the abdominal area are most commonly used.
Sterility is crucial: Aseptic technique and proper vial handling are necessary to maintain product integrity.
Recommended tools: We use a 28-gauge needle and 1ml syringe for administration.
Dosage Recommendations
High-Dose Protocol (For serious and life-threatening conditions such as Cancer, HIV/AIDS, Hepatitis, and Tuberculosis)
Daily Dose: Up to 2500 ng GcMAF administered subcutaneously in the morning.
Vial Usage: 1ml daily drawn from a 7500 ng / 3ml vial.
Course Duration: A typical high-dose course spans 90 doses over 3 months (equivalent to 30 vials).
Follow-Up: Further courses may be advised at a reduced frequency depending on patient response and disease stage.
For lung-related cancers, half of the daily dose may be nebulized for localized effect.
Chronic Fatigue Syndrome (CFS) / Myalgic Encephalomyelitis (ME) Lower-Dose Protocol: Typically 1250 ng every 3 to 4 days.
Based on patient condition, higher or more frequent doses may be considered for increased therapeutic impact.
Key Considerations
Individualized Dosing: Final dosage and frequency are always determined by the treating professionals.
No Established Upper Limit: Clinical practice has not identified a definitive upper limit for GcMAF dosing.
Gcmaf should be avoided solely as a precaution if you have a heart condition. There is not enough scientific to prove this theory to date.
Ongoing Support: GcMAF therapy should be continued as long as the illness is active, and for a period thereafter, to help reduce the chance of recurrence.
Why GcMAF Matters:
GcMAF (Gc protein-derived Macrophage Activating Factor) plays a critical role in restoring immune system function by activating macrophages, vital cells that target pathogens and abnormal cells. For patients battling advanced illness, immune restoration is not just beneficial, it’s essential.
If you or a loved one are exploring immune-enhancing therapies for serious health conditions, GcMAF therapy, when properly administered and monitored, can be a powerful addition to your treatment strategy. For further GcMAF information please visit gcmaf.com. We used MicroproXtra GcMAF this can be purchased from dubaibioremedix.com
Written by Dr Fermin Celma
